Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.mayocp.2020.10.031 http://scihub22266oqcxt.onion/10.1016/j.mayocp.2020.10.031 33413819!7604017!33413819     free     free     free       Mayo+Clin+Proc 2021 ; 96 (1): 203-217 Nephropedia Template TP {{tp|p=33413819|t=2021. Coronavirus Disease 2019-Associated Coagulopathy |pdf=|usr=}}{{33413819}} gab.com Text Coronavirus Disease 2019-Associated Coagulopathy JO: Mayo Clin Proc http://www.kidney.de/pget.php?&tw=1&pmid=33413819 #FOAvip Patients with the severe form of coronavirus disease 2019 (COVID-19) have been frequently found to suffer from both arterial and venous thrombotic events due to the perpetuation of a hypercoagulable state. This phenomenon, termed COVID-19-associated coagulopathy, is now considered a major component of the pathophysiology of this novel infectious disease, leading to widespread thrombosis. While at first, the vascular insults may be limited to the pulmonary microvasculature, as the disease progresses, systemic involvement occurs, culminating in distant organ thrombosis and multiorgan dysfunction syndrome. In this review article, we discuss recent insights into the pathophysiologic mechanisms of COVID-19-associated coagulopathy and review the clinical, histopathologic, and laboratory evidence, which leads us to conclude that COVID-19 is both a pulmonary and vascular disorder. Twit Text FOAVip Coronavirus Disease 2019-Associated Coagulopathy ????Mayo Clin Proc http://www.kidney.de/pget.php?&tw=1&pmid=33413819 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33413819 #FOAvip English Wikipedia <ref>{{Cite pmid|33413819}}</ref> Coronavirus Disease 2019-Associated Coagulopathy #MMPMID33413819 Lippi G; Sanchis-Gomar F; Favaloro EJ; Lavie CJ; Henry BM Mayo Clin Proc 2021[Jan]; 96 (1): 203-217 PMID33413819show ga Patients with the severe form of coronavirus disease 2019 (COVID-19) have been frequently found to suffer from both arterial and venous thrombotic events due to the perpetuation of a hypercoagulable state. This phenomenon, termed COVID-19-associated coagulopathy, is now considered a major component of the pathophysiology of this novel infectious disease, leading to widespread thrombosis. While at first, the vascular insults may be limited to the pulmonary microvasculature, as the disease progresses, systemic involvement occurs, culminating in distant organ thrombosis and multiorgan dysfunction syndrome. In this review article, we discuss recent insights into the pathophysiologic mechanisms of COVID-19-associated coagulopathy and review the clinical, histopathologic, and laboratory evidence, which leads us to conclude that COVID-19 is both a pulmonary and vascular disorder. |Blood Coagulation Disorders/*etiology/*physiopathology[MESH] |COVID-19/*complications/*physiopathology[MESH] |Disease Progression[MESH] |Humans[MESH]Coronavirus Disease 2019-Associated Coagulopathy (epmc).pdf DeepDyve Pubget Overpricing